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There are several approaches under
investigation in view ot improvement ot the
therapeutic ratio ot NSCLC radiotherapy in our
Department:
1/ Dose escalation above 70 Gy using
contormal radiotherapy techniques, 2/
aecelerated radiotherapy with or without
induction chemotherapy addressed to III stage
tumours, 3/ contormal postoperative
radiotherapy to total minimum dose in PTV ot 50
Gy addressed to eompletely reseeted III stage
tumours.
Ad 1/ From XI 1998 to XI 2000 43 patients
were included in dose escalation study. Doses
trom 70 to 74 Gy were delivered. Apart trom one
toxie death, due to radiation pneumonitis,
toxieity was aeceptable. Sinee 1999 tor NO
patients the study ot omission ot elective
irradiation is eondueted. By the time being 10
patients were irradiated with omission ot elective
fields. There was no relapse in non-treated
"elective areas". The aetuarial 1-, 2- and 3-year
survival were respectively 84-, 64-, and 42%.
There were 14 local relapses in 19 progressions"
observed in the entire group. In spite of
encouraging results a high level of local
relapses shows the limits ot moderate dose
escalation using eonformai teehniques and
conventional fractionation in improvement of
local control ot NSCLC.
Ad 2/ From III 1999 two different accelerated
radiation therapy sehedules are investigated for
III stage tumours. Forty patients were enrolled in
the study: 26 were irradiated aceording to
accelerated hyperfraetionated radiotherapy (57
Gy in 40 fractions [first week: elective fields - 1.2
Gy x 2 per day, 3 remaining weeks 1.8 Gy to
elective tields and 1.2 Gy boost to tumour]
during 26 days), 14 were irradiated according to
accelerated conformal radiotherapy with
concurrent boost (56.7 Gy in 21 tractions and 26
days: all treatment was eonformally planned and
delivered: 1,9 Gy per fraction to the Iimited
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elective tield and 0.8 Gy as a concurrent boost
to the GTV). There was no difference on
compliance with treatment plan, toxicity and
response rate (80- and 72%) in the both
investigated groups.
Ad 3/ From I 1999 eleven patients were
enrolled in the phase II study of postoperative
contormal radiotherapy ot the region ot the
highest probability of microscopic invasion by
the disease to the minimum dose ot 50 Gy in
PTV. The study is conducted in view ot the
tuture design ot randomised study addressing
question of the value ot postoperative
radiotherapy using modern techniques in
management ot NSCLC.
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The capacity of recombinant human
keratinocyte growth tactor (rhKGF) to ameliorate
the radiation response ot mouse oral mucosa
and other epithelial tissues was recently
reported. However, the exact mechanisms of
action of KGF remain unclear. The aim of the
present study was to investigate the effect of
rhKGF on survival and colony size ot normai
human epidermal keratinoeytes in vitro. Primary
human neonatal keratinoeytes (HEKn) were
irradiated with doses ot O Gy and 2 Gy (200 kV
X-rays) and incubated in the presence or
absence of 100ng/ml rhKGF. Plating efficiency
(PE) and surviving traction (SF2) were
determined in a clonogenic assay. In celi
cultures without rhKGF the mean PE was 4.6%.
Irradiation with 2 Gy resulted in a SF2 of 51 %. In
celi eultures with rhKGF, the mean PE was
identical (4.6%). After irradiation with 2 Gy, a
similar SF2 ot 54% was observed, indieating
that KGF did not change the survival
characteristics ot HEKn keratinocytes. Individual
colony size, however, in all cultures ineubated
with rhKGF was significantly increased
compared to incubation without rhKGF. The
number ot extremely large eolonies (D2 mm)
was clearly higher (p=O.OOOO) with rhKGF-
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